Collaboration Announces Framework to Bolster COVID-19 Research
A new multi-company collaborative announced the launch of a new framework aimed at bolstering research and development of COVID-19 treatments. [...]
JCPH’s Nash Discusses Return to Normalcy After First Wave of COVID-19
Jefferson College of Public Health Founding Dean Emeritus David Nash says testing will be key as the U.S. looks to [...]
Report: Remdesivir Trials Posting Promising Results
Gilead's COVID-19 treatment, remdesivir, is showing some promise in clinical trials which have seen swift recoveries of symptoms in severe [...]
Report: Manufacturing Costs for Coronavirus Treatments Could Range on the Low End
Treatments for COVID-19, including hydroxychloroquine and remdesivir, could see very low manufacturing costs, according to a Bloomberg report. According to [...]
MedPAC to CMS: Exempt 2020 Data When Calculating Future Benchmarks
The Medicare Payment Advisory Commission (MedPAC) has asked the Centers for Medicare and Medicaid Services (CMS) to toss 2020 performance [...]
Mayo Clinic Develops Rapid-Detection Tool for COVID-19
A team of 230 Mayo Clinic experts has developed a new system that can rapidly identify which employees have been [...]
How COVID-19 is Impacting Outsourcing Engagements
A recent article on the Future of Sourcing looks at how the outsourcing industry can better navigate the challenges presented [...]
Health Care Industry Leveraging RWD to Combat COVID-19
The health care industry is looking to better leverage real-world data in the midst of the COVID-19 pandemic as it [...]
How Can Policymakers Act to Beat COVID-19?
A recent blog post published on the Baker Institute Blog looks at how policymakers could better combat the COVID-19 pandemic. [...]
Shah: COVID-19 Pandemic Proves Challenging for Evidence-Based Medicine
In a recent opinion piece published on STAT, Beth Israel Deaconess Medical Center Obstetrician Dr. Neel Shah says the COVID-19 [...]
Program Looks to Address Gaps in COVID-19 Data
The Robert Wood Johnson Foundation's Health Data for Action program is supporting a collaboration between Health Care Cost Institute (HCCI), [...]
Fear Not, MHT Partners’ Krause Tells Health Care Investors
Despite the "tremendous strain" on health care resources due to the COVID-19 pandemic, MHT Partners' Patrick Krause says signs point [...]
Column: Coronavirus Pulls Back Curtain on Health Rationing
In a recent guest column published in the Orlando Sentinel, Sue Peschin, president and CEO of the Alliance for Aging [...]
Report: BCBS of Michigan Paying Workers to Join COVID-19 Fight
In an effort to ramp up the fight against the COVID-19 pandemic, Blue Cross Blue Shield of Michigan is offering [...]
Fauci: Trump ‘Does Listen’
Anthony Fauci, the nation's top coronavirus expert, told JAMA in a recent interview that while President Donald Trump sometimes says [...]
Bricker Talks Wave 2 of COVID-19
How can payers and providers best prepare for a second wave in the COVID-19 pandemic? Compass Professional Health Services CMO [...]
Podcast Dives Into Cost-Sharing Provision of CARES Act
Attorney Doug Aldeen and Quizzify Founder Al Lewis in a Relentless Health Value podcast discuss a cost-sharing provision contained in [...]
Blog Post Highlights Impact Coronavirus Could Have on New Drug Launches
A recent blog post on Tribeca Knowledge outlines some of the key challenges pharmaceutical companies face regarding drug launches in [...]
Coronavirus Patients Look to New Gilead Drug
As the world rushes to find a treatment for COVID-19, coronavirus patients are looking to secure a spot in studies [...]
Shkreli Seeks Furlough to Research Potential COVID-19 Treatments
Disgraced biotech entrepreneur Martin Shkreli is requesting a 3-month furlough to research potential treatments for COVID-19, STAT reports. In a [...]
ISPOR 2020 Goes Virtual
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is moving its annual meeting into the virtual space in response [...]
Oracle Founder Looks to Partner with White House to Combat Coronavirus
Oracle Founder Larry Ellison is working with the Trump White House in a bid to use big data in the [...]
eyeforpharma Philadelphia Pivots to Virtual Event
In response to the COVID-19 outbreak, eyeforpharma is transitioning its eyeforpharma Philadelphia conference to a free, online event. The 4-day [...]
NICE Publishes COVID-19 Guidelines
The National Institute for Health and Care Excellence (NICE) on March 21 published a new set of guidelines that address [...]
Drugmaker Halves Price of Potentially Promising Coronavirus Treatment
New Jersey-based Rising Pharmaceuticals doubled the price of chloroquine in 2019, but the drugmaker, in response to the coronavirus pandemic, [...]
